Bu çeviri hazırlanıyor. Bu süre içinde İngilizce orijinal sürümü gösteriyoruz.
Düzenleme ve hukuk · 18.11.20201 dk okuma
Prospective Grant of Exclusive Patent License: Treatment and Prevention of Neuropathic Pain With P2Y14 Antagonists
Yerel otomatik çeviri · Kaynağın orijinal dili
Özet
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Saint Louis University, ("SLU"), a non-profit university located in Missouri, in its rights to the inventions and patents listed in the SUPPLEMENTARY INFORMATION section of this notice.
Kaynağın orijinal dili: Federal Register — All DocumentsOrijinal duyuruyu açın →